SCCOHT is no longer considered to belong to the family of neuroendocrine neoplasms because it appears to be associated with a germline or somatic mutation in the gene encoding for SMARCA4, an inactivating mutation responsible for reduced BRG1 protein expression and frequently found in rhabdoid tumors. The gene discussed is SMARCA4; the disease is rhabdoid tumor.